Overview

Pharmacokinetics and Metabolism of Hydrocodone Bitartrate Controlled-Release (HC-CR) in Subjects With Hepatic Impairment

Status:
Completed

Trial end date:
2011-05-01

Target enrollment:

Participant gender:

Summary

Determine the influence of hepatic impairment on the pharmacokinetics and metabolism of Hydrocodone Bitartrate Extended-Release (HC-ER) 20 mg capsules

Phase:

Phase 1

Details

Lead Sponsor:

Zogenix, Inc.

Treatments:

Hydrocodone